According to Takeda Pharmaceuticals, the average time taken to diagnose a rare disease without technology is 7.6 years, and that comes after countless tests and physician visits.
Late last month, pharmaphorum met with Stephen Majors, global head of communications for the Alliance for Regenerative Medicine (ARM), to discuss the latest developments in the Advanced The